NORTH CHICAGO, Ill. and
BALTIMORE, Dec. 5, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV),
a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today
announced that they signed a five-year collaboration agreement with
the goal of advancing medical oncology research and discovery at
both organizations.
Designed to build strong collaboration between AbbVie and Johns
Hopkins Medicine researchers, the agreement will focus on several
areas of oncology research, which could include lung, colorectal,
breast, prostate and hematological cancer.
"As an alumnus and a former faculty member of the Johns Hopkins University School of Medicine, I know
from my own experience that we will be able to combine AbbVie's
expertise in oncology with some of the most talented academic
researchers in the field of medicine today," said Gary Gordon, M.D., Ph.D., vice president,
oncology clinical development, AbbVie. "This collaboration will
combine our resources and talent with Johns Hopkins Medicine to
help further advance our ability to develop new therapies available
for cancer patients in need."
The agreement allows Johns Hopkins Medicine physicians and
scientists access to explore new therapies developed by AbbVie for
use in preclinical research funded by the collaboration. In
addition, the relationship includes opportunities for research and
development teams from both organizations to work closely to
promote scientific knowledge exchange. AbbVie also gains an option
for an exclusive license to certain Johns Hopkins Medicine
discoveries made under the agreement.
"The importance of cancer research is critical to developing new
therapies that could have life-changing implications," said
William Nelson, M.D., Ph.D.,
Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. "Opportunities to advance science
and further research help move us in a direction to yield positive
outcomes."
As part of the collaborative agreement, a joint steering
committee consisting of representatives from each organization will
determine the research projects that the collaboration will
undertake. Researchers from Johns
Hopkins and AbbVie will also participate in an annual
symposium to discuss their joint research and evaluate potential
new projects.
About AbbVie
AbbVie is a global,
research-based biopharmaceutical company formed in 2013 following
separation from Abbott Laboratories. The company's mission is to
use its expertise, dedicated people and unique approach to
innovation to develop and market advanced therapies that address
some of the world's most complex and serious diseases. Together
with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs
more than 28,000 people worldwide and markets medicines in more
than 170 countries. For further information on the company and its
people, portfolio and commitments, please visit www.abbvie.com.
Follow @abbvie on Twitter or view careers on our Facebook or
LinkedIn page.
About Johns Hopkins Medicine
Johns Hopkins Medicine
(JHM), headquartered in Baltimore,
Maryland, is an $8 billion
integrated global health enterprise and one of the leading academic
health care systems in the United
States. JHM unites physicians and scientists of the
Johns Hopkins University School of
Medicine with the organizations, health professionals and
facilities of The Johns Hopkins Hospital and Health System. JHM's
vision, "Together, we will deliver the promise of medicine," is
supported by its mission to improve the health of the community and
the world by setting the standard of excellence in medical
education, research and clinical care. Diverse and inclusive, JHM
educates medical students, scientists, health care professionals
and the public; conducts biomedical research; and provides
patient-centered medicine to prevent, diagnose and treat human
illness. JHM operates six academic and community hospitals, four
suburban health care and surgery centers, and 40 primary and
specialty care outpatient sites under the umbrella of Johns Hopkins
Community Physicians. JHM extends health care into the community
and globally through Johns Hopkins Home Care Group, Johns Hopkins
Medicine International and Johns Hopkins HealthCare. The Johns
Hopkins Hospital, opened in 1889, has been ranked #1 in the nation
by U.S. News & World Report for 22 years of the survey's
27-year history. For more information about Johns Hopkins Medicine;
its research, education and clinical programs; and for the latest
health, science and research news, visit
www.hopkinsmedicine.org.
Logo - http://photos.prnewswire.com/prnh/20160706/386913LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbvie-and-johns-hopkins-to-collaborate-on-cancer-research-300372462.html
SOURCE AbbVie